Previous Page
12-04 :: April/May 2012
nanotimes
Companies Facts
Advertisement
13
per diluted share on fully diluted weighted average shares outstanding of 56 million and using an effec- tive tax rate of 40%.
has announced that it treated the second and third patients with dry Age-related Macular Degeneration (AMD) in the Company’s US clinical trial with RPE cells derived from embryonic stem cells. The Com- pany currently has two clinical trial sites approved to participate in the ongoing clinical trial for dry AMD.
high-speed DRAM test system, the T5511. The new system, which begins shipping this month, offers the industry’s fastest test speed of 8Gbps. With a maxi- mum test speed of 8Gbps, the T5511 is the world’s fastest memory testers, supporting the very fastest GDDR5-SDRAM devices with capacity to spare. Furthermore, since all the system’s test pins support 8Gbps, no reduction in parallelism occurs when ope- rating at high speed.
A http://www.advantest.co.jp © Advantest Corp.
dvantest Corporation (TSE: 6857, NYSE: ATE) announced the availability of its next-generation
dvanced Cell Technology, Inc (OTCBB: ACTC), a leader in the field of regenerative medicine,